Jeffrey Meuler: Got it. And then great to see the progress on building the access to data for the insurance use case. Can you talk a bit more about the pipeline from a monetization perspective? I just don’t know how far out that is on the horizon. In the past you’ve made references to a potential large insurer in the U.S. that you’re in conversations with. I don’t think that’s come to fruition, just curious on monetizing the insurance use cases?
Richard Barlow: So as you noted, we made announcement yesterday where we now represent Ford in both Europe and the U.S. for their insurance marketplace. We are not yet giving 2023 guidance, but we now have our first European and U.S.-based wide insurance offering from an OEM and we expect that make a cyclical contribution to our revenues next year. Meanwhile having strategic support from Sompo puts us in a very firm place to be aligned with the partner in APAC and Japan and further field later on. That helps us scale our products without taking an unnecessary or expensive product deployment, which may €“ will not drive the revenues in the short-term. So we’re navigating through support from Sompo, the great support now from Ford on European and U.S. base is somewhere we’re excited about what insurance can do this next year, but we’re not yet giving 2023 guidance.
Jeffrey Meuler: Right. And then on gross bookings, just what’s the cause of the change in the estimate of prior period bookings and how material is that? Just trying to understand I guess the quality of the gross bookings metric and the potential for other revisions to prior periods.
John Maxwell: There is no revision to prior periods as much as there was. The way of timing, the gross bookings metric is important to us to help you understand how we’re booking business. So you take the million dollars that we booked in Q3, that’s a low quarter for us actually. We had several million dollars of deals that were actually signed in early October that were originally slated and we thought they would come in, in September, they didn’t. And so you’re always going to have timing and I even though as we talk about revenue as we come into the end of the year, we expect to get to $10 million plus, but there’s always timing factors that could cause something to slip into the next quarter. We’re focused really on building our business, and the building of the business is very strong.
That shows up in gross bookings. It’s showing up in our revenue, it’s showing up in our ARR and we think that will continue as we go. So there’s not really any factor that would cause that other than
Jeffrey Meuler: Doesn’t the release say there was also a change in the estimate of prior period bookings?
John Maxwell: I have to get back to you. I don’t know. I guess, I’m not sure what that is, so.
Jeffrey Meuler: Okay. And then you got into some contract specifics on like the full-year guidance. So you have about a little over $2.5 million of revenue already booked from things that you subsequently sold and then a little over that that you need to still sell and recognize this revenue, I guess in the final month of the quarter. Is that correct?
John Maxwell: Yes. I mean that’s
Jeffrey Meuler: I guess just given that some of your contracts result in revenue being recognized over longer periods of time, not always in period, just trying to understand just line of sight or confidence and potentially getting to that number. It sounds like there’s a decent risk that maybe it slips.